January 19 2022
The hybrid style symposium (on-site and online), organized by Dr. Goro Sashida of IRCMS, Kumamoto University, Japan, had been held as a part of JSPS Core-to-Core Program "Integrative approach for normal and leukemic stem cells" on January 13th and 14th, 2022. Under the theme of hematopoiesis and leukemia, seventeen speakers from respected research institutes in and out of Japan had introduced their researches.
With about 70 participants from Japan and other counrties, the speakers and participants had discussed actively about their ongoing projects. The future research collaborations are expected to be launched.
【Speakers】
< Day 1 >
Dr. Ayako Ishizu
Professor, Tokyo Women's Medical University (Japan)
Dr. Fumio Arai
Professor, Kyushu University (Japan)
Dr. Hitoshi Takizawa
Professor, IRCMS, Kumamoto University (Japan)
Dr. Atsushi Hirao
Professor, Kanazawa University (Japan)
Dr. Kenichi Miharada
Professor, IRCMS, Kumamoto University (Japan)
Dr. Takaomi Sanda(Online)
PI, CSI, National University of Singapore (Singapore)
Dr. Tomohiko Tamura
Professor, Yokohama City University (Japan)
Dr. Toshio Suda
Director/Distinguished Professor, IRCMS, Kumamoto University (Japan)
Dr. Jonas Larsson(Online)
Professor, Lund University (Sweden)
Dr. Elisa Laurenti(Online)
Assistant Professor, Cambridge Stem Cell Institute, University of Cambridge (UK)
<Day 2>
Dr. Mamiko Sakata
Professor, University of Tsukuba (Japan)
Dr. Goro Sashida
Professor, IRCMS, Kumamoto University (Japan)
Dr. Akihiko Yokoyama(Online)
PI, National Cancer Center (Japan)
Dr. Atsushi Iwama
Professor, University of Tokyo (Japan)
Dr. Issay Kitabayashi
Chief, National Cancer Center (Japan)
Dr. Takuro Nakamura
Vice Director, The Cancer Institute of JFCR (Japan)
Dr. Toshio Kitamura
Professor, University of Tokyo (Japan)
【Speakers and Chairs】